Nothing Special   »   [go: up one dir, main page]

CO2018008288A2 - Virus de la tilapia de tipo ortomixo - Google Patents

Virus de la tilapia de tipo ortomixo

Info

Publication number
CO2018008288A2
CO2018008288A2 CONC2018/0008288A CO2018008288A CO2018008288A2 CO 2018008288 A2 CO2018008288 A2 CO 2018008288A2 CO 2018008288 A CO2018008288 A CO 2018008288A CO 2018008288 A2 CO2018008288 A2 CO 2018008288A2
Authority
CO
Colombia
Prior art keywords
virus
ortomixo
type tilapia
tilapia virus
type
Prior art date
Application number
CONC2018/0008288A
Other languages
English (en)
Spanish (es)
Inventor
Arnon Dishon
Shlomit Tal
Original Assignee
Kovax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kovax Ltd filed Critical Kovax Ltd
Publication of CO2018008288A2 publication Critical patent/CO2018008288A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CONC2018/0008288A 2016-01-10 2018-08-06 Virus de la tilapia de tipo ortomixo CO2018008288A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662276873P 2016-01-10 2016-01-10
US201662352570P 2016-06-21 2016-06-21
PCT/IL2017/050027 WO2017118989A1 (en) 2016-01-10 2017-01-10 Orthomyxo-like virus of tilapia

Publications (1)

Publication Number Publication Date
CO2018008288A2 true CO2018008288A2 (es) 2018-08-21

Family

ID=59274499

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2018/0008288A CO2018008288A2 (es) 2016-01-10 2018-08-06 Virus de la tilapia de tipo ortomixo

Country Status (6)

Country Link
EP (1) EP3400007A4 (de)
CN (1) CN108778324A (de)
BR (1) BR112018014042A2 (de)
CO (1) CO2018008288A2 (de)
MX (1) MX2018008529A (de)
WO (1) WO2017118989A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108624718A (zh) * 2018-06-20 2018-10-09 上海海洋大学 恒温实时检测罗非鱼湖病毒的rpa试剂盒及其专用引物和探针
WO2021165957A1 (en) 2020-02-17 2021-08-26 Atlantium Technologies Ltd Immune-enhanced aquaculture
CN112194710A (zh) * 2020-08-19 2021-01-08 佛山科学技术学院 罗非鱼湖病毒s8基因编码的重组蛋白、由其制备的抗体及应用
NL2028806B1 (en) * 2021-07-22 2022-06-03 Univ Northwest A&F Tilv-2 protein or gene encoding tilv-2 protein in preparation of subunit vaccine against tilapia lake virus
CN113718061B (zh) * 2021-09-30 2023-06-09 厦门海关技术中心 一种同时检测罗湖病毒和病毒性神经坏死病毒的双重rt-pcr的引物组,试剂盒和方法
CN113755645B (zh) * 2021-09-30 2023-06-09 厦门海关技术中心 一种检测罗湖病毒的荧光定量rt-pcr引物对和探针,试剂盒和检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
WO2016100328A1 (en) * 2014-12-15 2016-06-23 The Trustees Of Columbia University In The City Of New York Novel tilapia virus and uses thereof

Also Published As

Publication number Publication date
EP3400007A4 (de) 2019-08-28
MX2018008529A (es) 2019-06-06
EP3400007A1 (de) 2018-11-14
BR112018014042A2 (pt) 2019-02-12
WO2017118989A1 (en) 2017-07-13
CN108778324A (zh) 2018-11-09

Similar Documents

Publication Publication Date Title
CO2018008288A2 (es) Virus de la tilapia de tipo ortomixo
EA201790532A1 (ru) Способы и композиции для ослабления иммунных ответов против вирусного вектора для переноса
PH12017500858A1 (en) Mocrocyclic peptides useful as immunomodulators
EA201890493A1 (ru) РЕПРЕССОРЫ Htt И ИХ ПРИМЕНЕНИЕ
EA030115B9 (ru) Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
MA40765B1 (fr) Méthodes et compositions d'induction d'une immunité protectrice contre l'infection par le virus de l'immunodéficience humaine
MX2020004543A (es) Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan.
CU24580B1 (es) Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas
MY179251A (en) Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development
CL2018000513A1 (es) Vacunas de pestivirus para temblores congénitos
EA202091567A1 (ru) Химерные белки мти
EP3104883A4 (de) Impfstoffe gegen tilapia-virus
BR112017008097A2 (pt) método para tratar condições oculares
MX2018014955A (es) Vacunas atenuadas vivas del virus de la influenza equina.
CL2016001745A1 (es) Ácido (s)-3'-metil-abscísico y ésteres del mismo
PE20190225A1 (es) Un metodo para reducir la contaminacion de huevo
EA201691203A1 (ru) Твёрдые формы тенофовира
CL2016002256A1 (es) Un proceso mejorado para la preparación de exametazima
EP3600404A4 (de) Entwicklung eines alternativen modifizierten influenza-b-virus-lebendimpfstoffs
AR103281A1 (es) COMPOSICIONES, APARATOS Y MÉTODOS PARA DETERMINAR EL pH DE UNA SOLUCIÓN DE ANALITO
CL2022001509A1 (es) Vacuna inactivada contra el ortoreovirus de los peces.
侯荣彦 It’s Me
张岚 Live Like You’re Dying
CL2019000555S1 (es) Licuadora.
呱呱 HEROS